CUSIP: 74319FAB3
What is CUSIP 74319FAB3?
CUSIP 74319FAB3 identifies 74319FAB3 - BIORA THERAPEUTICS INC - NOTE 7.250%12/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 74319FAB3:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q4 | $0 | $0 | -$1,502,753 | 0 | |
| 2024 Q3 | $2,600,000 | $1,502,753 | 57.8% | 1 | |
| 2024 Q2 | $2,600,000 | $1,487,933 | 57.23% | 1 | |
| 2024 Q1 | $2,600,000 | $1,512,469 | -$3,322,125 | 58.17% | 1 |
| 2023 Q4 | $8,225,000 | $4,846,960 | -$37,484,617 | 58.85% | 2 |
| 2023 Q3 | $78,527,200 | $43,680,176 | -$26,131,723 | 54.78% | 6 |
| 2023 Q2 | $128,527,200 | $75,624,273 | 56.37% | 6 | |
| 2023 Q1 | $134,527,200 | $75,796,994 | +$966 | 53.58% | 6 |
| 2022 Q4 | $128,527,200 | $71,400,554 | 53.56% | 6 | |
| 2022 Q3 | $128,527,200 | $79,879,583 | +$1,478,583 | 62.77% | 6 |
| 2022 Q2 | $126,027,200 | $81,132,000 | -$1,231,033 | 63.32% | 5 |
| 2022 Q1 | $127,028,200 | $92,810,000 | -$275,750 | 71.21% | 5 |
| 2021 Q4 | $129,226,000 | $93,505,000 | +$93,505,000 | 68.43% | 5 |